AstraZeneca PLC ADR closed 14.96% below its 52-week high of $87.68, which the company achieved on August 30th.

AstraZeneca PLC outperforms 2024 earnings estimates but faces challenges in 2025. Read why AZN patent expiries and mixed ...

AstraZeneca PLC ADR closed 14.68% short of its 52-week high of $87.68, which the company achieved on August 30th.

London's FTSE 100 index surged to a new record, driven by AstraZeneca's positive results and the anticipation of a rate cut from the Bank of England. AstraZeneca led the gains, with its stock rising 5 ...

The FTSE 100 is up 1.3 per cent in late morning trading, reaching a new record high. The index is lifted by shares of AstraZeneca after upbeat results, and ahead of an anticipated rate cut from ...

Though their jewelry is mostly dainty, their high-shine finish makes them really stand out. Plus, I have a nickel allergy, which means that low-quality instantly gives me a rash. Every piece I've ...

AstraZeneca on Thursday warned that it could ... penalty that GSK was levied in a high-profile China bribery scandal back in 2013, or compared to the $6.4 billion in sales that AZ generated ...

In a report released today, Peter Welford from Jefferies maintained a Hold rating on AstraZeneca (AZN – Research Report), with a price target of £109.00. The company’s shares opened today at ...

Strong performances by AstraZeneca and mining stocks today helped ... Guidance for 2025 pointed to revenues growth at a high single-digit percentage and core earnings at a low double-digit ...

The government has defended its negotiations with AstraZeneca, after the pharmaceutical giant ditched a planned £450m investment last week, blaming a shortfall in government funding. Science ...

Rachel Reeves was dealt yet another blow after AstraZeneca cancelled a planned £450 million investment in a vaccine manufacturing plant. The chancellor came under fire on GB News for "making an ...